Congress expands drug discounts to rural emergency hospitals serving the uninsured
H.R. 44 — Rural 340B Access Act of 2025 · Filed by Jack Bergman (R-MI) · 6 cosponsors · Introduced Jan 3, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill expands the federal 340B drug discount program to include rural emergency hospitals, allowing them to purchase certain prescription drugs at significantly reduced prices. Rural emergency hospitals that are government-owned, government-empowered nonprofits, or private nonprofits with contracts to serve low-income uninsured patients become eligible for the discount, potentially lowering their drug costs and enabling them to serve rural communities more affordably.
Why we flagged it
The bill's sole operative mechanism is to extend an existing federal drug-discount program to a specific class of underserved healthcare providers. It is a straightforward eligibility expansion with no hidden provisions or narrow carve-outs.
What the text implies
- Rural emergency hospitals may face administrative burden in demonstrating compliance with 340B eligibility criteria (ownership structure, low-income service contracts), potentially creating barriers for smaller or less-resourced facilities.
- The discount may be captured by private nonprofit rural emergency hospitals with state contracts, not just government-owned facilities, creating a potential subsidy pathway for private operators serving public missions.
The full analysis lists 3 implications of this text.
Who stands to gain
rural emergency hospitals (government-owned, nonprofit, and private nonprofit operators); pharmaceutical manufacturers (potential volume effects on 340B rebate obligations)